Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment...

hemophilia business, known as Bioverativ. The hemophilia business would become an independent publicly traded company. Bioverativ offered two hemophilia drugs...

achievements. In January 2018, Sanofi announced that it would acquire Bioverativ for $11.6 billion and days later announced that it would acquire Ablynx...

BioLineRx (2003– ) BioMarin (1997– ) bioMérieux (1963– ) BiondVax (2003– ) Bioverativ (2016– ) Biovista (2005– ) Bliss (1984– ) Bluepharma (1990s– ) Boehringer...

from his alma mater in 2010. Harris was EVP of Research & Development at Bioverativ until it was acquired by Sanofi in 2018. From 2011 to 2016, He worked...

Hersha Hospitality Trust to Join S&P SmallCap 600" (PDF). "LogMeIn and Bioverativ Set to Join the S&P MidCap 400; Others to Join S&P SmallCap 600" (PDF)...

for haemophilia A. In its partnership with Pfizer in 2017, Sangamo uses Bioverativ in hemoglobinopathies such as beta thalassemia and sickle cell disease...

43 2017 Gilead Sciences Kite Pharma Acquisition 11.9 15 44 2018 Sanofi Bioverativ Acquisition 11.6 14 45 2011 Gilead Sciences Pharmasset Acquisition 11...

Tebentafusp Immunocore HLA-A*02:01–positive uveal melanoma Sutimlimab Bioverativ cold agglutinin disease Lutetium (177Lu) vipivotide tetraxetan Novartis...

in response to cold and stress). This medication is being developed by Bioverativ, a Sanofi company. Sutimlimab was approved for medical use in the United...